Over the past twenty years, the use of dietary supplements, fortified foods, and nutraceuticals has burgeoned, backed by an expanding corpus of scientific studies. These investigations have primarily focused on their biological effects and mechanisms, initially through in vitro examination, followed by efficacy assessments in animal models. With numerous products showing promising outcomes in these preliminary phases, the field now moves towards validating these findings through rigorous clinical trials.
This research endeavor is not only scientific but also carries profound ethical dimensions. Currently available as over-the-counter items, nutraceuticals and dietary supplements are often marketed directly to consumers who lack the necessary information regarding their clinical backing. It is imperative that health claims associated with these products are substantiated by stringent scientific proof to ensure consumer safety and enhance trust in these supplements.
To deepen our understanding within this framework, submissions are encouraged that provide fresh clinical insights concerning the efficacy of these products on human health. Articles might cover a variety of related topics, including but not limited to:
• Cardiovascular health enhancements through dietary supplements
• The role of nutraceuticals in managing metabolic syndrome
• Dietary supplement influences on muscle pathology
• Nutraceutical applications in geriatric care
• Benefits of dietary supplements in dermatology and trichology
• Interventions with supplements as adjuncts to conventional pharmaceutical treatments
Studies that are purely in vitro or utilize only animal models will be considered outside the scope of this collection, except where they address ADME aspects of complex nutraceutical formulations and present substantial scientific intrigue at the editors’ discretion.
Topic Editor Ettore Novellino is a scientific advisor for NGN Healthcare. All other Topic Editors declare no conflicts of interest.
Keywords:
dietary supplements, clinical trials, nutraceuticals, CVD, metabolic syndrome
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Over the past twenty years, the use of dietary supplements, fortified foods, and nutraceuticals has burgeoned, backed by an expanding corpus of scientific studies. These investigations have primarily focused on their biological effects and mechanisms, initially through in vitro examination, followed by efficacy assessments in animal models. With numerous products showing promising outcomes in these preliminary phases, the field now moves towards validating these findings through rigorous clinical trials.
This research endeavor is not only scientific but also carries profound ethical dimensions. Currently available as over-the-counter items, nutraceuticals and dietary supplements are often marketed directly to consumers who lack the necessary information regarding their clinical backing. It is imperative that health claims associated with these products are substantiated by stringent scientific proof to ensure consumer safety and enhance trust in these supplements.
To deepen our understanding within this framework, submissions are encouraged that provide fresh clinical insights concerning the efficacy of these products on human health. Articles might cover a variety of related topics, including but not limited to:
• Cardiovascular health enhancements through dietary supplements
• The role of nutraceuticals in managing metabolic syndrome
• Dietary supplement influences on muscle pathology
• Nutraceutical applications in geriatric care
• Benefits of dietary supplements in dermatology and trichology
• Interventions with supplements as adjuncts to conventional pharmaceutical treatments
Studies that are purely in vitro or utilize only animal models will be considered outside the scope of this collection, except where they address ADME aspects of complex nutraceutical formulations and present substantial scientific intrigue at the editors’ discretion.
Topic Editor Ettore Novellino is a scientific advisor for NGN Healthcare. All other Topic Editors declare no conflicts of interest.
Keywords:
dietary supplements, clinical trials, nutraceuticals, CVD, metabolic syndrome
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.